In a follow-up to her recent white paper on the future of the biotech sector, our resident virologist and portfolio manager Dr Bianca Ogden chats with Douglas Isles on how increased funding and computing power is transforming the healthcare sector. We learn what motivated Bianca to become a scientist and then switch careers to investing, and why she believes biotechs will continue to disrupt and change the healthcare sector over the next decade and beyond.
Disclaimer
DISCLAIMER: The above information is commentary only (i.e. our general thoughts). It is not intended to be, nor should it be construed as, investment advice. To the extent permitted by law, no liability is accepted for any loss or damage as a result of any reliance on this information. Before making any investment decision you need to consider (with your financial adviser) your particular investment needs, objectives and circumstances.